Calvary Mater Newcastle Hospital
Hospital
Location:
Waratah,
Australia (AU)
ISNI: 0000000087629215
ROR: https://ror.org/04kbz1397
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024)
Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al.
Journal article
ESTRO-ACROP guideline on surface guided radiation therapy (2022)
Freislederer P, Batista V, Ollers M, Buschmann M, Steiner E, Kugele M, Fracchiolla F, et al.
Journal article